🇺🇸 FDA
Patent

US 11439669

C. novyi for the treatment of solid tumors in humans

granted A61KA61K2035/11A61K31/65

Quick answer

US patent 11439669 (C. novyi for the treatment of solid tumors in humans) held by Biomed Valley Discoveries, Inc. expires Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Biomed Valley Discoveries, Inc.
Grant date
Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
45
CPC classes
A61K, A61K2035/11, A61K31/65, A61K35/74, A61K35/742